Diacerein orphan drug development for epidermolysis bullosa simplex: A phase 2/3 randomized, placebo-controlled, double-blind clinical trial
Journal of the American Academy of Dermatology | Feb 09, 2018
Clinical experience with ceftazidime/avibactam for treatment of antibiotic-resistant organisms other than Klebsiella pneumoniae
International Journal of Antimicrobial Agents | Feb 08, 2018
Cefoxitin-based antibiotic therapy for ESBL-producing Enterobacteriaceae prostatitis: A prospective pilot-study
International Journal of Antimicrobial Agents | Feb 08, 2018
Most read this week